Photonic biosensing at the point-of-care

Steiner, Daniel J., Nazareth College; Bryan, Michael R., Univ. of Rochester Medical Ctr.; Miller, Benjamin L.

doi:10.1117/3.100303.ch8

Book: Biophotonics and Biosensing: From Fundamental Research to Clinical Trials Through Advances of Signal and Image Processing

Editor(s): Andrea Armani; Tatevik Chalyan; David D. Sampson

Chapter Author(s): Daniel Steiner, Michael Bryan, Benjamin Miller

Published: 2024

https://doi.org/10.1117/3.100303.ch8

Author Affiliations +

Abstract

Diagnostic technology is becoming as familiar to consumers as the cell phone, and in some cases actually is the cell phone. Whether it’s the watch-integrated heart rate and step count monitors many of us wear 24 hours a day, to the COVID-19 lateral flow assays (LFAs), which became ubiquitous over the course of the SARS-CoV-2 pandemic, people have access to dramatically more information about their health than previously thought possible. However, despite this avalanche of new consumer-grade technology, there is still a tremendous amount of diagnostic information not available at the consumer level, or even in a doctor’s office. To bridge that gap and bring us ever closer to the “tricorder” idea popularized in Star Trek, researchers in academia and industry around the globe are developing new technologies suitable for use at the point-of-care (PoC).